Health

Alzheimer’s disease is a debilitating condition that currently has no cure. However, recent research has identified that our diet may play a significant role in increasing or decreasing our risk of developing the disease. A review of 38 studies conducted over the last five years concluded that the Western diet pattern is a risk factor
0 Comments
Eli Lilly, a US pharmaceutical company, has announced encouraging clinical trial results for its new Alzheimer’s medication, donanemab. The experimental drug has demonstrated in a late-stage trial that it can slow cognitive decline by 35%, by targeting amyloid plaques in the brain, a common hallmark of Alzheimer’s disease. Beta-amyloid, a protein that plays an important
0 Comments
A recent study conducted by neuroscientist Frank Scheer, from Brigham and Women’s Hospital in Boston, suggests that eating earlier in the day can positively impact our biological weight regulation in three significant ways. The three ways are through the number of calories burned, our hunger levels, and the way our bodies store fat. The research
0 Comments
Researchers from the University of Helsinki and the University of Eastern Finland have found that a particular genus of microbe, commonly found in wet and boggy environments, could play a critical role in Parkinson’s disease. The researchers discovered that the microbe generates compounds that activate proteins inside brain cells to form toxic clumps. These findings
0 Comments